In this Letter we describe the optimization of an aminopurine lead (1) with modest potency and poor overall kinase selectivity which led to the identification of a series of potent, selective JNK inhibitors. Improvement in kinase selectivity was enabled by introduction of an aliphatic side chain at the C-2 position. CC-359 (2) was selected as a potential clinical candidate for diseases manifested by ischemia reperfusion injury.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2011.12.028 | DOI Listing |
Publication Analysis
Top Keywords
jnk inhibitors
8
ischemia reperfusion
8
reperfusion injury
8
kinase selectivity
8
aminopurine based
4
based jnk
4
inhibitors prevention
4
prevention ischemia
4
injury letter
4
letter describe
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!